Heska (HSKA) Tops Q2 EPS by 8c, Updates Outlook
Tweet
Share
E-mailGet Alerts HSKA Hot Sheet
Price: $119.99 --0%
Financial Fact:
Other vaccines, pharmaceuticals and products: 7.04M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other vaccines, pharmaceuticals and products: 7.04M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Heska (NASDAQ: HSKA) reported Q2 EPS of $0.24, $0.08 better than the analyst estimate of $0.16. Revenue for the quarter came in at $29.7 million versus the consensus estimate of $30.12 million.
GUIDANCE:
Heska sees Q3 2018 revenue of $31 million, versus the consensus of $34.58 million.
Heska sees FY2018 revenue of $139 million, versus the consensus of $139.1 million.
For earnings history and earnings-related data on Heska (HSKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- InspireMD (NSPR) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
